BRAF NP_004324.2:p.V600X
1 clinical trials · Condition
◉ Watch BRAF NP_004324.2:p.V600X
| Record | Firm | Date |
|---|---|---|
| Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery (NCT01787500) | M.D. Anderson Cancer Center | 2013-02-15 |
Track BRAF NP_004324.2:p.V600X automatically
Every clearance here is in the API, with alerts when new ones post.